CING Competitors & Alternatives

Compare Cingulate Inc with similar stocks in the same industry

Biotechnology

CING

Main Stock
$4.76
+26.93%
Tradestie Score
43
Market Cap
$23.49M
Analyst Upside
+345.4%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Timed Release Drug Delivery
Competitive Moat: None
Core Technology Stack: Precision Timed Release (PTR) platform, methylphenidate formulations
Major Customers 4
psychiatrists neurologists ADHD patients specialty pharmacies
Critical Suppliers 2
contract manufacturing organizations API suppliers
Direct Ecosystem Rivals 3

Top Competitors

221 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SRZN Surrozen, Inc. Common
$30.16
-6.68%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$25.11
-7.41%
$110.20M - 34 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.03
+0.17%
$84.52M - 53 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.20
-3.74%
$67.94M - 52 Compare
SPRC SciSparc Ltd. Ordinary Shares
$0.32
-3.72%
$9.78M 0.0 49 Compare
CDIO Cardio Diagnostics Holdings Inc. Common stock
$1.75
-2.23%
$7.51M - 39 Compare
BBLG Bone Biologics Corp Common Stock
$0.29
-1.94%
$5.01M - 42 Compare
DRMA Dermata Therapeutics, Inc. Common Stock
$0.58
-3.14%
$3.50M - 42 Compare
VRAX Virax Biolabs Group Limited Ordinary Shares
$0.43
-4.02%
$2.69M - 40 Compare
KMPH KMPH
- - - - Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)

221 stocks in this industry